In a developmental
toxicity study (MRID number if available) [Chemical name (% a.i.)] was administered to [(# of females) strain, species]/dose in [diet, water, by capsule, by gavage] at dose
levels of 0, x, x, or x mg/kg bw/day from days
[#] through [#]
of gestation.

[Describe
maternal toxicity briefly. If none, state that there were no treatment-related
effects in mortality, clinical signs, body weight, food consumption, or
cesarean parameters].The maternal
LOAEL is mg/kg bw/day, based on [endpoint].
The maternal NOAEL is mg/kg bw/day.Describe
effects at doses >LOAEL.

[Describe
developmental toxicity briefly. If none, state that there were no
treatment-related effects in developmental parameters].The developmental LOAEL is
mg/kg bw/day, based on [endpoint]. The developmental NOAEL is mg/kg bw/day.Describe effects at doses >LOAEL.

The
developmental toxicity study in the rat is classified [acceptable, unacceptable(why);
note if it is a range-finding study] and satisfies (does not satisfy) the guideline requirement for a
developmental toxicity study (OPPTS 870.3700; OECD 414) in [species]. [If it does not
satisfy the requirement, concisely list only major deficiencies or refer to
deficiency section.]